Indications of Alzheimer's disease may be evident decades before first signs of cognitive impairment

Mar 28, 2011

Researchers at Mount Sinai School of Medicine have found that patients with Alzheimer's disease have lower glucose utilization in the brain than those with normal cognitive function, and that those decreased levels may be detectable approximately 20 years prior to the first symptoms of Alzheimer's disease. This new finding could lead to the development of novel therapies to prevent the eventual onset of Alzheimer's. The study is published online in the journal Translational Neuroscience.

Using modified to develop Alzheimer's disease, the research team found that when β-amyloid, an abnormal protein linked to Alzheimer's disease, starts to become detectable in the in its soluble toxic form, the mitochondria, or "power plants" of the cell where glucose is converted into energy, became impaired. Within the equivalent of about 20 human years, mice with decreased energy metabolism developed signs of Alzheimer's disease such as cognitive defects and impairment of the synaptic terminal, the area of brain cells important in memory formation.

"This evidence in mice validates that the diagnosis of probable Alzheimer's disease may be the end result of impairment in brain cell energy production," said the study's lead author, Giulio M. Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry, Geriatrics, and Adult Development at Mount Sinai School of Medicine. "Identifying that mitochondrial impairment is evident years earlier than cognitive defects is a major breakthrough."

"This new evidence could revolutionize the way we design interventions," said Merina T. Varghese, MD, co-author of the study and Postdoctoral Fellow in Neurology at Mount Sinai School of Medicine. "This study sets the stage for the development of potential novel preventions or therapies to apply in humans, even when they have normal cognitive function, to prevent the eventual onset of Alzheimer's disease."

Explore further: The effects of rapid diagnostic tests for malaria in African healthcare settings

Provided by The Mount Sinai Hospital

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Researchers find new Alzheimer's disease treatment promising

Jul 12, 2009

Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The ...

Education protects against pre-Alzheimer's memory loss

Oct 20, 2008

ST. PAUL, Minn. – People with more education and more mentally demanding occupations may have protection against the memory loss that precedes Alzheimer's disease, according to a study published in the October 21, 2008, ...

Study finds certain drugs cut Alzheimer's

Dec 06, 2006

U.S. scientists say they've identified anti-hypertensive agents that can prevent cognitive decline and amyloid neuropathology in Alzheimer patients.

Recommended for you

Researchers discover target for treating dengue fever

14 hours ago

Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other ...

Tracking flu levels with Wikipedia

14 hours ago

Can monitoring Wikipedia hits show how many people have the flu? Researchers at Boston Children's Hospital, USA, have developed a method of estimating levels of influenza-like illness in the American population by analysing ...

User comments : 3

Adjust slider to filter visible comments by rank

Display comments: newest first

kevinrtrs
1 / 5 (2) Mar 29, 2011
Mmmmmhhhh, perhaps I don't quite understand but there doesn't seem to be a clear link between the study on mice and the extrapolation to humans. Who/what says that what happens in the mice is the same as in humans? Like I said - perhaps I lack insight.
Ethelred
5 / 5 (2) Mar 29, 2011
The link is that humans and mice have BRAINS. brains that use very similar, though not identical, chemistry.

Research with mice is faster, cheaper and less liable to have severe ethical issues than testing humans. The human tests come later. Sometimes it doesn't work out the same with humans but it does often enough to make it a better way to do things overall.

For one thing researches can kill and then dissect the brains of mice without waiting for them to die months (decades with humans) later. Do that with humans and I suspect that there might just happen to be some legal problems.

Ethelred
Skultch
not rated yet Apr 01, 2011
One of my most desperate hopes is that we figure this out before it affects my 60 yr old mother. Her mother is completely debilitated by this disease right now.

More news stories

Leeches help save woman's ear after pit bull mauling

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

Male monkey filmed caring for dying mate (w/ Video)

(Phys.org) —The incident was captured by Dr Bruna Bezerra and colleagues in the Atlantic Forest in the Northeast of Brazil.  Dr Bezerra is a Research Associate at the University of Bristol and a Professor ...

Scientists tether lionfish to Cayman reefs

Research done by U.S. scientists in the Cayman Islands suggests that native predators can be trained to gobble up invasive lionfish that colonize regional reefs and voraciously prey on juvenile marine creatures.